Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 9/20 | 0.36 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7807878 | 0.83 | POLB (0.42) | ALDH1A1FFAR4TRPV3POLBKAT6A | |
| SCHEMBL18970383 | 0.81 | KIF11 (0.38) | ALDH1A1 | |
| SCHEMBL12896068 | 0.80 | SLC6A4 (0.43) | ALDH1A1FFAR4KAT6AKMT2APDK2 | |
| SCHEMBL13361927 | 0.77 | PTPN7 (0.43) | KAT6AKMT2APDK2 | |
| SCHEMBL19413082 | 0.73 | RIPK1 (0.41) | — | |
| SCHEMBL129753 | 0.73 | ALDH1A1 (0.44) | ALDH1A1FFAR4POLBKAT6AKMT2A | |
| SCHEMBL1020456 | 0.73 | ALDH1A1 (0.47) | ALDH1A1FFAR4TRPV3POLBKAT6A | |
| SCHEMBL30829775 | 0.73 | ALDH1A1 (0.47) | ALDH1A1FFAR4TRPV3POLBKAT6A | |
| SCHEMBL8372012 | 0.73 | ALDH1A1 (0.44) | ALDH1A1FFAR4POLBNPSR1KMT2A | |
| SCHEMBL7815438 | 0.73 | ALDH1A1 (0.41) | ALDH1A1TRPV3POLBKAT6AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023519-B2 | Cyclobutane containing carboxylic acid GPR120 modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-07-17 | — | — | US | disclosed |
| US-20170247311-A1 | CYCLOBUTANE CONTAINING CARBOXYLIC ACID GPR120 MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2017-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023519-B2 | Cyclobutane containing carboxylic acid GPR120 modulators | GPR68, GPR88, GPR55 | ALDH1A1 2093/4885FFAR4 34/4885TRPV3 268/4885 |
| US-20170247311-A1 | CYCLOBUTANE CONTAINING CARBOXYLIC ACID GPR120 MODULATORS | GPR68, GPR88, GPR55 | ALDH1A1 2093/4885FFAR4 34/4885TRPV3 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.